Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Therapeutic Innovation and Regulatory Science is Scopus-indexed (Q1, CiteScore 4.3), WoS SCIE. It is covered by India's One Nation One Subscription scheme for reading access. Published by Springer Science and Business Media Deutschland GmbH.
Checked against the index lists dated .
ISSN 2168-4790Verify ISSN ↗2168-4804Verify ISSN ↗
Publisher: Springer Science and Business Media Deutschland GmbH
Cost to publish: About US$4,090 to publish open access (publisher list price, via OpenAlex) — subscription publishing may be free
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Pharmacology, Toxicology and Pharmaceutics (miscellaneous) | 12 / 57 | 79th | Q1 |
| Public Health, Environmental and Occupational Health | 231 / 725 | 68th | Q2 |
| Pharmacology (medical) | 123 / 278 | 55th | Q2 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2013–present (also 2008–2011, 1974–2006, 1972, 1970), best quartile Q1, CiteScore 4.3.
Therapeutic Innovation and Regulatory Science is Q1 in Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (rank 12 of 57), Q2 in Public Health, Environmental and Occupational Health (rank 231 of 725) and Q2 in Pharmacology (medical) (rank 123 of 278), by CiteScore 2025.
Therapeutic Innovation and Regulatory Science is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 4.3, which places it in quartile Q1 at the 79th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.902, quartile Q1, with an H-index of 57.
The publisher lists an article processing charge of about US$4,090 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Therapeutic Innovation and Regulatory Science is published by Springer Science and Business Media Deutschland GmbH. Its print ISSN is 2168-4790 and its online ISSN is 2168-4804.
Yes. It is part of the One Nation One Subscription (ONOS) national subscription, so readers at participating Indian institutions get its full text. ONOS does not cover its article processing charge.
Yes — indexed in the Science Citation Index Expanded.
No — it is not registered as an open-access journal in DOAJ or Scopus.
Therapeutic Innovation and Regulatory Science has an h-index of 50 and a 2-year mean of 2.13 citations per paper (OpenAlex). Its Scopus CiteScore is 4.3, quartile Q1. On 2-year citations it ranks #17 of 52 Scopus journals in Pharmacology, Toxicology and Pharmaceutics (miscellaneous).
Therapeutic Innovation and Regulatory Science published 168 papers in 2025; its busiest recent year was 2020 with 223. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 93 research articles (2026), authors are most often from United States (35.1%), Japan (12.9%) and China (7%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 2 retracted papers are recorded (1.1 per 1,000 papers). The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.